December 1, 2025 · Form 4 insider transaction
Smith Edward F bought 35,000 shares of BENITEC BIOPHARMA INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.